期刊文献+

血管生成素-2在结核性和恶性胸腔积液鉴别诊断中的价值

Angiopoietin-2 level in differential diagnosis between tuberculous and malignant pleural effusion
下载PDF
导出
摘要 目的探讨血管生成素-2(angiopoietin-2,Ang-2)在结核性和恶性胸腔积液鉴别诊断中的意义。方法采用酶联免疫吸附法(ELISA)检测48例恶性胸腔积液患者和42例结核性胸腔积液患者胸腔积液中Ang-2的含量。结果恶性胸腔积液中Ang-2含量为(48.4±21.5)ng/L,明显高于结核性胸腔积液(20.8±13.6)ng/L,两者比较差异有统计学意义(t=6.817,P<0.05);以31.6 ng/L为临界值,Ang-2对恶性胸腔积液诊断的敏感度为87.5%,特异性为76.2%,准确性为82.2%。结论胸腔积液中Ang-2的测定可作为鉴别结核性和恶性胸腔积液的指标。 Objective To investigate the role of angiopoietin-2( Ang-2) level in differential diagnosis between tuberculous and malignant pleural effusion. Methods Ang-2 level was detected with enzyme linked immunosorbent assay( ELISA) in 48 samples of malignant pleural effusion and 42 samples of tuberculous pleural effusion. Results The level of Ang-2 in malignant pleural effusion was significantly higher than that in tuberculous pleura effusion [( 48. 4 ± 21. 5) ng / L vs( 20. 8 ± 13. 6) ng / L,t = 6. 817,P 0. 05]. With the cut-off value of 31. 6 ng / L,the sensitivity,specificity and accuracy of Ang-2 for the diagnosis of malignant pleural effusion were 87. 5%,76. 2% and 82. 2%,respectively.Conclusion Ang-2 might be used as an indicator for the differential diagnosis of tuberculous and malignant pleural effusion.
出处 《实用肿瘤杂志》 CAS 2015年第3期259-261,共3页 Journal of Practical Oncology
关键词 诊断 鉴别 胸腔积液 血管生成素2 胸腔积液 恶性 结核 酶联免疫吸附测定 diagnosis differential pleural effusion angiopoietin-2 pleural effusion malignant tuberculosis enzymelinked immunosorbent assay
  • 相关文献

参考文献10

  • 1童康尔,李志丹,朱伟伟,左芬,彭涛.鸦胆子油乳剂治疗恶性胸腔积液疗效观察[J].实用肿瘤杂志,2012,27(4):433-435. 被引量:8
  • 2董西林,王雅娟,李家芝,徐晶,周晶.胸腔积液中肿瘤坏死因子、癌胚抗原和神经元特异性烯醇化酶的检测及诊断价值研究[J].实用肿瘤杂志,2009,24(2):139-142. 被引量:4
  • 3Economidou F, Margaritopoulos G, Antoniou KM, et al. The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications [ J ]. Exp Ther Med,2010,1 ( 1 ) :3 - 7.
  • 4史轩丰,邱志雄,薛飞.血管生成素-2在恶性胸腔积液中的诊断价值[J].临床肺科杂志,2012,17(6):1074-1075. 被引量:1
  • 5Xu C, Hao K, Yu L, et al. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer [ J ]. Siomarkers, 2014,19 ( 4):287 - 290.
  • 6Fett JW, Strydom DJ, Lobb RR, et al. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells [ J ]. Biochemistry, 1985,24 ( 20 ) : 5480 - 5486.
  • 7Wang HL, Deng CS, Lin J, et al. Expression of angiopoietin-2 is correlated with vascularization and tumor size in human colorectal adenoearcinoma [ J ]. Tohoku J Exp Med,2007,213( 1 ) :33 -40.
  • 8Shimoyama S, Kamlnishi M. Angiogenin in sera as all independent prognostic factor in gastric cancer [ J ]. J Cancer Res Clin Onco1,2003,129 (4) :239 - 244.
  • 9Fernandez M, Semela D, Bruix J, et al. Angiogenesis in liver disease [ J ]. J Hepato1,2009,50 ( 3 ) : 604 - 620.
  • 10Chao Y, Li CP, Chau GY, et al. Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with reseetable hepatocellular carcinoma after surgery [ J ]. Ann Surg Onco1,2003,10 ( 4 ) : 355 - 362.

二级参考文献25

  • 1林宏英,吴建梅,张文生.鸦胆子油的研究进展[J].中国实验方剂学杂志,2006,12(4):65-69. 被引量:106
  • 2师国强.榄香烯乳胸腔内注射治疗恶性胸腔积液的疗效观察[J].实用诊断与治疗杂志,2007,21(5):373-374. 被引量:22
  • 3谢艳萍,聂森,王飞,吴洁.鸦胆子油乳联合顺铂胸腔灌注治疗恶性胸腔积液临床观察[J].临床肺科杂志,2007,12(8):809-810. 被引量:15
  • 4Alatas F, Alatas O, Metintaas M, et al. Diagnostic value of CEA,CA153,CA199,CYFRA21-1,NSE and TSA assay in pleural effusions [J].Lung Cancer, 2001,31(1):9--16.
  • 5Ando S,Kimura H,Iwai N,et al. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer [J].Anticancer Res, 2001,21 (413) : 3085--3092.
  • 6Trape J, Buxo J, Perez OJ, et al. Tumor markers as prognostic factors in treated non-small cell lung cancer[J]. Anticancer Res, 2003,23 (56) :4277-- 4281.
  • 7Baughman RP, Lower EE. An inhibitor of tumor necrosis fator found in pleural effusions [J].J Lab Clin Med, 1991,118(2) : 326-- 331.
  • 8Trap J, Buxo J, Prrezde J, et al. Tumor markers prognostic factors in treated non-small cell lung cancer [J]. Anticancer Res, 2003,23(5b) 14277--4281.
  • 9Pujol JL, Boher JM, Grenier J, et al. Cyfra21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients [J]. Lung Cancer, 2001,31 (2) : 221 -- 231.
  • 10Hsieh MY, Lin ZY, Chuang WL. Serial serum VEGF-A, angiopoi- etin-2, and endostatin measurements in cirrhotic patients with hepa- tocellular carcinoma treated by transcatheter arterial chemoemboliza- tion[J]. Kaohsiung J Med Sci, 2011, 27(8) :314-22.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部